APA
ALDR

American Portfolios Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

American Portfolios Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-500
Closed -$5.88K – 2934
2019
Q2 		$5.88K Hold
500
– – ﹤0.01% 2117
2019
Q1 		$6.83K Buy
500
+300
+150% +$3.89K ﹤0.01% 1970
2018
Q4 		$2.05K Hold
200
– – ﹤0.01% 2134
2018
Q3 		$3.33K Buy
+200
New +$3.62K ﹤0.01% 2125

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Portfolios Advisors's ALDR Position: Q3 2019 in Review

American Portfolios Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 500 shares — an estimated $5.88K sold.

American Portfolios Advisors first reported a position in ALDR in Q3 2018 and held it in 4 quarters. The position peaked at $6.83K in Q1 2019. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • American Portfolios Advisors reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 500 Alder Biopharmaceuticals shares in Q3 2019, an estimated $5.88K.
  • American Portfolios Advisors first reported a position in Alder Biopharmaceuticals in Q3 2018 and held it in 4 quarters.
  • American Portfolios Advisors's Alder Biopharmaceuticals position peaked at $6.83K in Q1 2019.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on American Portfolios Advisors's 13F filing for Q3 2019, filed 24 Mar 2023.